Anti-obesity Medication (Naltrexon/Bupropion) in Obesity Management: Single-Centre Early Experience.
- Published in:
- Malaysian Journal of Medical Sciences, 2025, v. 32, n. 2, p. 42, doi. 10.21315/mjms-11-2024-879
- By:
- Publication type:
- Article
Works about BUPROPION
Results: 794
1
2
AKT answer relating to stopping smoking in pregnancy.
- Published in:
- InnovAiT, 2025, v. 18, n. 7, p. e872, doi. 10.1177/17557380251349688m
- Publication type:
- Article
3
Smoking cessation.
- Published in:
- InnovAiT, 2025, v. 18, n. 7, p. 376, doi. 10.1177/17557380251331521
- By:
- Publication type:
- Article
4
What interventions support people in quitting smokeless tobacco use?
- Published in:
- Journal of Primary Health Care, 2025, v. 17, n. 2, p. 200, doi. 10.1071/HC25097
- By:
- Publication type:
- Article
5
Stimulants, atomoxetine most efficacious in short term for adult ADHD.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 4, p. 8, doi. 10.1002/pu.31295
- Publication type:
- Article
6
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 12, p. 9, doi. 10.1002/pu.31248
- Publication type:
- Article
7
Small differences in weight gain risk among commonly used antidepressants.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 11, p. 6, doi. 10.1002/pu.31230
- Publication type:
- Article
8
Atomoxetine and bupropion interaction.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 2, doi. 10.1002/pu.31131
- By:
- Publication type:
- Article
9
Study gauges impact of long‐term adjunctive antidepressant in bipolar depression.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 12, p. 1, doi. 10.1002/pu.31094
- Publication type:
- Article
10
Naltrexone plus bupropion effective as maintenance therapy for binge eating disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 10, p. 6, doi. 10.1002/pu.31073
- Publication type:
- Article
11
Bupropion does not show benefit relative to placebo for cocaine use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 3, doi. 10.1002/pu.31035
- Publication type:
- Article
12
Treatment‐resistant geriatric depression improves after adding aripiprazole.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 6, p. 1, doi. 10.1002/pu.31019
- Publication type:
- Article
13
Both naltrexone‐bupropion and weight loss therapy effective for binge eating disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 2, p. 4, doi. 10.1002/pu.30973
- Publication type:
- Article
14
Approvals.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 8, doi. 10.1002/pu.30956
- Publication type:
- Article
15
Opioid use disorder treatments also improve stimulant use outcomes.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 10, p. 1, doi. 10.1002/pu.30923
- Publication type:
- Article
16
Dextromethorphan‐bupropion shows efficacy in two depression trials.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 9, p. 1, doi. 10.1002/pu.30912
- Publication type:
- Article
17
Review: Combining antidepressants superior to monotherapy in acute depression.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 6, p. 1, doi. 10.1002/pu.30876
- By:
- Publication type:
- Article
18
Optimal therapy for smokers combines drugs, behavioral support.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 6, p. 7, doi. 10.1002/pu.30882
- Publication type:
- Article
19
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 6, p. 9, doi. 10.1002/pu.30737
- Publication type:
- Article
20
The ghost of Heisenberg, or: methamphetamine, again.
- Published in:
- 2021
- By:
- Publication type:
- Film/TV Criticism and Review
21
Bupropion plus naltrexone shows some benefit in stimulant use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 1, doi. 10.1002/pu.30713
- Publication type:
- Article
22
Several treatments effective for smoking cessation in patients with schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 12, p. 3, doi. 10.1002/pu.30653
- Publication type:
- Article
23
Bupropion does not improve apathy in Alzheimer's patients.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 9, p. 8, doi. 10.1002/pu.30622
- Publication type:
- Article
24
Smoking‐cessation treatments generally safe for patients with psychiatric disorders.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 6, p. 4, doi. 10.1002/pu.30435
- Publication type:
- Article
25
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 9, p. 6, doi. 10.1002/pu.30354
- Publication type:
- Article
26
Aripiprazole augmentation of antidepressant improves chance of remission in VA population.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 11, p. 1, doi. 10.1002/pu.30270
- Publication type:
- Article
27
YOUR MEDICATION INFORMATION.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, p. 1, doi. 10.1002/pu.30254
- Publication type:
- Article
28
Drug Safety Communication.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 8, doi. 10.1002/pu.30224
- Publication type:
- Article
29
Groundbreaking smoking cessation study highlights safety of varenicline, bupropion.
- Published in:
- Brown University Psychopharmacology Update, 2016, v. 27, n. 8, p. 1, doi. 10.1002/pu.30158
- Publication type:
- Article
30
RESEARCH ROUNDUP.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 7, p. 7, doi. 10.1002/pu.30062
- Publication type:
- Article
31
Drug combination in maternal depression not more effective for children.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 5, p. 1, doi. 10.1002/pu.30042
- Publication type:
- Article
32
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 12, p. 8
- Publication type:
- Article
33
Varenicline with bupropion helps smoking abstinence in NRT nonresponders.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 10, p. 4
- Publication type:
- Article
34
Delirium associated with bupropion and risperidone.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 5, p. 2
- By:
- Publication type:
- Article
35
Bupropion hydrochloride (generic).
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, p. 1
- Publication type:
- Article
36
Bupropion effective for smoking treatment nonresponders.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 8, p. 7
- Publication type:
- Article
37
Labeling revision for Wellbutrin.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 5, p. 8
- Publication type:
- Article
38
FDA changes Budeprion XL bioequivalence ratings.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 4, p. 7
- Publication type:
- Article
39
For Alzheimer Agitation, a Novel, Oral NMDA Inhibitor Could be the Next Targeted Treatment.
- Published in:
- Patient Care (Online), 2025, p. 6
- By:
- Publication type:
- Article
40
Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
41
Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2116595, doi. 10.1001/jamanetworkopen.2021.16595
- By:
- Publication type:
- Article
42
Error in Affiliations.
- Published in:
- 2021
- Publication type:
- Correction Notice
43
Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 1, p. 1, doi. 10.1001/jamanetworkopen.2020.32053
- By:
- Publication type:
- Article
44
A Case of Treating Cathinone Dependence and Comorbid Depression Using Bupropion.
- Published in:
- Journal of Psychoactive Drugs, 2012, v. 44, n. 5, p. 434, doi. 10.1080/02791072.2012.736851
- By:
- Publication type:
- Article
45
USO INDEBIDO DE BUPROPIÓN POR INSUFLACIÓN NASAL CON DESENLACE FATAL: REPORTE DE UN CASO Y REVISIÓN.
- Published in:
- Actas Espanolas de Psiquiatria, 2023, v. 51, n. 2, p. 84
- By:
- Publication type:
- Article
46
Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity.
- Published in:
- Antioxidants, 2023, v. 12, n. 6, p. 1208, doi. 10.3390/antiox12061208
- By:
- Publication type:
- Article
47
A Lazarus effect: A case report of Bupropion overdose mimicking brain death.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
48
Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 681, doi. 10.1002/cpdd.915
- By:
- Publication type:
- Article
49
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 299, doi. 10.1002/cpdd.844
- By:
- Publication type:
- Article
50
Amenamevir: Studies of Potential CYP2C8‐ and CYP2B6‐Mediated Pharmacokinetic Interactions With Montelukast and Bupropion in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 860, doi. 10.1002/cpdd.578
- By:
- Publication type:
- Article